Exact Mass: 209.1335506
Exact Mass Matches: 209.1335506
Found 87 metabolites which its exact mass value is equals to given mass value 209.1335506,
within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error
0.001 dalton.
Minoxidil
C - Cardiovascular system > C02 - Antihypertensives > C02D - Arteriolar smooth muscle, agents acting on > C02DC - Pyrimidine derivatives C78274 - Agent Affecting Cardiovascular System > C270 - Antihypertensive Agent C78274 - Agent Affecting Cardiovascular System > C29707 - Vasodilating Agent D002317 - Cardiovascular Agents > D000959 - Antihypertensive Agents D002317 - Cardiovascular Agents > D014665 - Vasodilator Agents D - Dermatologicals KEIO_ID M035; [MS2] KO009058 KEIO_ID M035
Minoxidil
Minoxidil is only found in individuals that have used or taken this drug. It is a potent direct-acting peripheral vasodilator (vasodilator agents) that reduces peripheral resistance and produces a fall in blood pressure. (From Martindale, The Extra Pharmacopoeia, 30th ed, p371)Minoxidil is thought to promote the survival of human dermal papillary cells (DPCs) or hair cells by activating both extracellular signal-regulated kinase (ERK) and Akt and by preventing cell death by increasing the ratio of BCl-2/Bax. Minoxidil may stimulate the growth of human hairs by prolonging anagen through these proliferative and anti-apoptotic effects on DPCs. Minoxidil, when used as a vasodilator, acts by opening adenosine triphosphate-sensitive potassium channels in vascular smooth muscle cells. This vasodilation may also improve the viability of hair cells or hair follicles. C - Cardiovascular system > C02 - Antihypertensives > C02D - Arteriolar smooth muscle, agents acting on > C02DC - Pyrimidine derivatives C78274 - Agent Affecting Cardiovascular System > C270 - Antihypertensive Agent C78274 - Agent Affecting Cardiovascular System > C29707 - Vasodilating Agent D002317 - Cardiovascular Agents > D000959 - Antihypertensive Agents D002317 - Cardiovascular Agents > D014665 - Vasodilator Agents D - Dermatologicals
2,5-Dimethoxy-4-methylamphetamine
D018377 - Neurotransmitter Agents > D018490 - Serotonin Agents > D017366 - Serotonin Receptor Agonists D002491 - Central Nervous System Agents > D011619 - Psychotropic Drugs > D006213 - Hallucinogens
Bamethan
C - Cardiovascular system > C04 - Peripheral vasodilators > C04A - Peripheral vasodilators > C04AA - 2-amino-1-phenylethanol derivatives C78272 - Agent Affecting Nervous System > C29747 - Adrenergic Agent > C87053 - Adrenergic Agonist D002317 - Cardiovascular Agents > D014665 - Vasodilator Agents
2-[Bis-(2-hydroxy-ethyl)-amino]-2-hydroxymethyl-propane-1,3-diol
2,5-Dimethoxy-4-methylamphetamine
D018377 - Neurotransmitter Agents > D018490 - Serotonin Agents > D017366 - Serotonin Receptor Agonists D002491 - Central Nervous System Agents > D011619 - Psychotropic Drugs > D006213 - Hallucinogens
3c-methyl-(4ar,10at,10bc)-decahydro-pyrano[2,3-g]indolizin-1-one|Elaeokanin D|Elaeokanine D
Nicotinoylcholine
[C11H17N2O2]+ (209.12899620000002)
IPB_RECORD: 231; CONFIDENCE confident structure
1-(2,4-DIMETHYL-PHENOXY)-3-METHYLAMINO-PROPAN-2-OL
Fepradinol
D018373 - Peripheral Nervous System Agents > D018689 - Sensory System Agents C254 - Anti-Infective Agent > C28394 - Topical Anti-Infective Agent D002491 - Central Nervous System Agents > D000700 - Analgesics D000893 - Anti-Inflammatory Agents D018501 - Antirheumatic Agents
3-Fluoro-4-(4-methyl-1-piperazinyl)aniline
C11H16FN3 (209.13281879999997)
4-AMINO-5-IODO-2-(TRIFLUOROMETHYL)-BENZENECARBONITRILE
2-(Cyclopropylmethyl)hexahydrocyclopenta[c]-pyrrole-3a(1H)-carboxylic acid
1-Methyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-1,2,3-triazole
Bis-tris methane
D019995 - Laboratory Chemicals > D002021 - Buffers COVID info from PDB, Protein Data Bank Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS
2-ISOPROPOXY-3-TRIMETHYLSILANYL-PYRIDINE
C11H19NOSi (209.12358439999997)
3-methoxy-N-[(4-methoxyphenyl)methyl]propan-1-amine
Ethanol, 2-[[1-(4-ethoxyphenyl)ethyl]amino]- (9CI)
3-methoxy-N-[(3-methoxyphenyl)methyl]propan-1-amine
(4-METHOXY-BENZYL)-(2-METHOXY-1-METHYL-ETHYL)-AMINE
tert-butyl 3,4,5-trimethyl-1H-pyrrole-2-carboxylate
Mirogabalin
N - Nervous system > N02 - Analgesics > N02B - Other analgesics and antipyretics > N02BF - Gabapentinoids C78272 - Agent Affecting Nervous System > C241 - Analgesic Agent > C2198 - Nonnarcotic Analgesic
2-Octyl cyanoacrylate
D001697 - Biomedical and Dental Materials > D014014 - Tissue Adhesives
[6-Aminomethyl-3-ethylbicyclo[3.2.0]hept-3-en-6-yl]acetic acid
5,5-Dimethyl-3-(morpholin-4-yl)cyclohex-2-en-1-one
Silanamine, N-((4-methoxyphenyl)methyl)-1,1,1-trimethyl-
C11H19NOSi (209.12358439999997)
Aniline, N-[2-(trimethylsiloxy)ethyl]-
C11H19NOSi (209.12358439999997)
2-phenoxy-N-trimethylsilylethanamine
C11H19NOSi (209.12358439999997)
1-Carboxyethylaminomethyl-4-Aminomethylbenzene
C11H17N2O2+ (209.12899620000002)
Bamethan
C - Cardiovascular system > C04 - Peripheral vasodilators > C04A - Peripheral vasodilators > C04AA - 2-amino-1-phenylethanol derivatives C78272 - Agent Affecting Nervous System > C29747 - Adrenergic Agent > C87053 - Adrenergic Agonist D002317 - Cardiovascular Agents > D014665 - Vasodilator Agents
Trimethyl-[2-(pyridine-3-carbonyloxy)ethyl]azanium
C11H17N2O2+ (209.12899620000002)
(1E,3S,4Z)-7-amino-1-[3-[(E)-prop-1-enyl]oxiran-2-yl]hepta-1,4-dien-3-ol
N,N-diethyl-4-methoxy-1-pyridin-1-iumcarboxamide
C11H17N2O2+ (209.12899620000002)
Phenethylamine, p-(trimethylsiloxy)-
C11H19NOSi (209.12358439999997)
Pyridine, 2-(3-trimethylsilyloxypropyl)-
C11H19NOSi (209.12358439999997)
2-Phenyl-2-trimethylsiloxyethylamine
C11H19NOSi (209.12358439999997)
(3S,4R)-3-ethyl-4-[(3-methyl-1H-imidazol-3-ium-4-yl)methyl]-2-oxolanone
C11H17N2O2+ (209.12899620000002)